Zebra BioSolutions service
AI-Assisted Drug Discovery
Computational prioritization governed by scientific review.
Engagement capabilities
Target and biomarker discovery
Virtual screening and molecular docking
ADME and toxicity prediction
Lead optimization with human expert review
All regulatory, scientific, AI-assisted and due-diligence conclusions are preliminary until reviewed and approved by qualified personnel. IP services do not constitute legal advice.